Literature DB >> 8635856

Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China.

B T Ji1, M C Hatch, W H Chow, J K McLaughlin, Q Dai, G R Howe, Y T Gao, J F Fraumeni.   

Abstract

To examine the possible role of body size and reproductive factors in pancreatic cancer, data were analyzed from a population-based case-control study conducted in Shanghai, China. Cases (n = 451) were permanent residents of Shanghai, 30-74 years of age, newly diagnosed with pancreatic cancer between October 1, 1990, and June 30, 1993. Deceased cases (19%) were excluded from the study. Controls (n = 1,552) were randomly selected from permanent Shanghai residents and frequency-matched to cases by gender and age. Information on body size and reproductive and other possible risk factors was collected through personal interviews. After adjustment for age, income, smoking and other confounders, a positive dose-response relation between body mass index and risk of pancreatic cancer was observed in both sexes. Among women, the risk of pancreatic cancer was significantly associated with number of pregnancies and live births. Compared with 0-2 pregnancies or live births, the odds ratio (OR) for 8 or more pregnancies was 1.90, while that for 5 or more births was 1.88. A modest elevation in risk, independent of parity, was associated with early age at first birth. Risk increased over 40% among women with a first birth at or before age 19 years relative to those at age 26 years or older. Ever use of oral contraceptives was associated with excess risk, though based on small numbers of users. Our findings suggest that, in Shanghai, obesity, gravidity, parity and perhaps use of oral contraceptives are associated with moderate increases in risk of pancreatic cancer, indicating that hormonal determinants deserve further investigation.

Entities:  

Mesh:

Year:  1996        PMID: 8635856     DOI: 10.1002/(SICI)1097-0215(19960516)66:4<432::AID-IJC4>3.0.CO;2-X

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

Review 1.  Obesity as a risk factor for certain types of cancer.

Authors:  K K Carroll
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

Review 2.  Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis.

Authors:  Gundula Behrens; Carmen Jochem; Daniela Schmid; Marlen Keimling; Cristian Ricci; Michael F Leitzmann
Journal:  Eur J Epidemiol       Date:  2015-03-15       Impact factor: 8.082

3.  Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.

Authors:  Li Jiao; Amy Berrington de Gonzalez; Patricia Hartge; Ruth M Pfeiffer; Yikyung Park; D Michal Freedman; Mitchell H Gail; Michael C R Alavanja; Demetrius Albanes; Laura E Beane Freeman; Wong-Ho Chow; Wen-Yi Huang; Richard B Hayes; Jane A Hoppin; Bu-Tian Ji; Michael F Leitzmann; Martha S Linet; Cari L Meinhold; Catherine Schairer; Arthur Schatzkin; Jarmo Virtamo; Stephanie J Weinstein; Wei Zheng; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Causes Control       Date:  2010-04-10       Impact factor: 2.506

4.  Association of menstrual and reproductive factors with pancreatic cancer risk in women: findings of the Japan Collaborative Cohort Study for Evaluation of Cancer Risk.

Authors:  Yingsong Lin; Shogo Kikuchi; Akiko Tamakoshi; Takashi Kawamura; Yutaka Inaba; Michiko Kurosawa; Yutaka Motohashi; Kiyoko Yagyu; Yuki Obata; Teruo Ishibashi
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

5.  Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS.

Authors:  Eunjung Lee; Pamela L Horn-Ross; Rudolph P Rull; Susan L Neuhausen; Hoda Anton-Culver; Giske Ursin; Katherine D Henderson; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2013-09-05       Impact factor: 4.897

6.  Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4).

Authors:  Leila Lujan-Barroso; Wei Zhang; Sara H Olson; Yu-Tang Gao; Herbert Yu; Peter A Baghurst; Paige M Bracci; H Bas Bueno-de-Mesquita; Lenka Foretová; Steven Gallinger; Ivana Holcatova; Vladimír Janout; Bu-Tian Ji; Robert C Kurtz; Carlo La Vecchia; Pagona Lagiou; Donghui Li; Anthony B Miller; Diego Serraino; Witold Zatonski; Harvey A Risch; Eric J Duell
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

7.  A case-control study of reproductive factors, female hormone use, and risk of pancreatic cancer.

Authors:  Yuqing Zhang; Patricia F Coogan; Julie R Palmer; Brian L Strom; Lynn Rosenberg
Journal:  Cancer Causes Control       Date:  2009-11-26       Impact factor: 2.506

8.  Association of body mass index and risk of death from pancreas cancer in Asians: findings from the Asia Cohort Consortium.

Authors:  Yingsong Lin; Rong Fu; Eric Grant; Yu Chen; Jung Eun Lee; Prakash C Gupta; Kunnambath Ramadas; Manami Inoue; Shoichiro Tsugane; Yu-Tang Gao; Akiko Tamakoshi; Xiao-Ou Shu; Kotaro Ozasa; Ichiro Tsuji; Masako Kakizaki; Hideo Tanaka; Chien-Jen Chen; Keun-Young Yoo; Yoon-Ok Ahn; Habibul Ahsan; Mangesh S Pednekar; Catherine Sauvaget; Shizuka Sasazuki; Gong Yang; Yong-Bing Xiang; Waka Ohishi; Takashi Watanabe; Yoshikazu Nishino; Keitaro Matsuo; San-Lin You; Sue K Park; Dong-Hyun Kim; Faruque Parvez; Betsy Rolland; Dale McLerran; Rashmi Sinha; Paolo Boffetta; Wei Zheng; Mark Thornquist; Ziding Feng; Daehee Kang; John D Potter
Journal:  Eur J Cancer Prev       Date:  2013-05       Impact factor: 2.497

9.  Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai.

Authors:  Karin A Rosenblatt; Dao L Gao; Roberta M Ray; Zakia C Nelson; Karen J Wernli; Wenjin Li; David B Thomas
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

Review 10.  Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.

Authors:  Rachael Z Stolzenberg-Solomon; Laufey T Amundadottir
Journal:  Hematol Oncol Clin North Am       Date:  2015-08       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.